Lv4
530 积分 2024-08-07 加入
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
5天前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
7天前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
7天前
已完结
ACNP 63rd Annual Meeting: Poster Abstracts P1-P304
1个月前
已完结
The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis
2个月前
已完结
Prevalence and clinical features of adult atopic dermatitis in tertiary hospitals of China
2个月前
已完结
Phenotypic analysis of atopic dermatitis in children aged 1-12 months: elaboration of novel diagnostic criteria for infants in China and estimation of prevalence
2个月前
已完结
Prevalence of Atopic Dermatitis in Chinese Children aged 1–7 ys
2个月前
已完结
Prevalence and Incidence of Atopic Dermatitis: A Systematic Review
2个月前
已完结
The Dawn of a New Era in Atopic Dermatitis Treatment
2个月前
已完结
皖公网安备34019202002308
